Abstract

Lack of routine surveillance in countries endemic for bovine tuberculosis (TB) and limited laboratory support contributes to the inability to differentiate the Mycobacterium tuberculosis Complex species, leading to an underestimated burden of the disease. Here, Whole-Genome Sequencing of Mycobacterium bovis isolated from tissues with TB-like lesions obtained from cattle and buffalos at Marajó Island, Brazil, demonstrates that recent transmission of M. bovis is ongoing at distinct sites. Moreover, the M. bovis epidemiology in this setting is herein found to be dominated by an endemic and unique clade composed of strains evolved from a common ancestor that are now genetically differentiated from other M. bovis clades. Additionally, envisioning a rapid strain differentiation and tracing across multiple settings, 28 globally validated strain-specific SNPs were identified, three of which considered as robust markers for the M. bovis Marajó strain. In conclusion, this study contributes with data regarding the identification of a novel M. bovis phylogenetic clade responsible for ongoing transmission events in both cattle and buffalo species in Brazil, provides a framework to investigate the dissemination of this highly prevalent strain and, holds the potential to inform TB control strategies that may help to prevent the spread of bovine and zoonotic TB.

Details

Title
Phylogenomic Perspective on a Unique Mycobacterium bovis Clade Dominating Bovine Tuberculosis Infections among Cattle and Buffalos in Northern Brazil
Author
Conceição Marília Lima da 1 ; Conceição Emilyn Costa 2   VIAFID ORCID Logo  ; Perini, Furlaneto Ismari 3 ; Silva Sandro Patroca da 4 ; Guimarães Arthur Emil dos Santos 5 ; Gomes, Pedro 6 ; Boschiroli, María Laura 7 ; Michelet Lorraine 7 ; Kohl, Thomas Andreas 8   VIAFID ORCID Logo  ; Kranzer Katharina 9 ; Francez Loreno da Costa 10 ; Lima Luana Nepomuceno Gondim Costa 4 ; Portugal, Isabel 6 ; Perdigão João 6 ; Lima Karla Valéria Batista 5 

 State University of Pará, Belém, Brazil (GRID:grid.442052.5); Evandro Chagas Institute, Anandideua, Brazil (GRID:grid.419134.a) (ISNI:0000 0004 0620 4442); Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal (GRID:grid.9983.b) (ISNI:0000 0001 2181 4263) 
 Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (GRID:grid.8536.8) (ISNI:0000 0001 2294 473X); Oswald Cruz Foundation, Rio de Janeiro, Brazil (GRID:grid.8536.8) 
 State University of Pará, Belém, Brazil (GRID:grid.442052.5) 
 Evandro Chagas Institute, Anandideua, Brazil (GRID:grid.419134.a) (ISNI:0000 0004 0620 4442) 
 State University of Pará, Belém, Brazil (GRID:grid.442052.5); Evandro Chagas Institute, Anandideua, Brazil (GRID:grid.419134.a) (ISNI:0000 0004 0620 4442) 
 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal (GRID:grid.9983.b) (ISNI:0000 0001 2181 4263) 
 French Agency for Food, Environmental and Occupational Health and Safety, Maisons-Alfort, France (GRID:grid.15540.35) (ISNI:0000 0001 0584 7022) 
 Leibniz Research Center Borstel, Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170); German Center for Infection Research (DZIF), Heidelberg, Germany (GRID:grid.452463.2) 
 Research Center Borstel Leibniz Lung Center, National Reference Center for Mycobacteria, Borstel, Germany (GRID:grid.418187.3) (ISNI:0000 0004 0493 9170); London School of Hygiene and Tropical Medicine, London, UK London School of Hygiene and Tropical Medicine, Clinical Research Department, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X) 
10  Federal Rural University of Amazon, Belém, Brazil (GRID:grid.8991.9) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2350892060
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.